Home › Guide · Updated October 22, 2026
Tirzepatide: The Complete Brief
This brief collects our coverage of tirzepatide: how it works, what the trials comparing it with semaglutide found, and how compounded GLP-1 products differ from the FDA-approved brands.
Start with how it works, then the comparisons.
Start here
- What Is Tirzepatide? How the Dual GIP and GLP-1 Medication Works
One weekly injection acting on two hormone pathways. How it works and who it is for. Updated October 9, 2026
Comparisons
- How to Get a GLP-1 Through Telehealth
The steps from online intake to pharmacy, brand vs compounded, and the FDA's warning signs. Updated October 22, 2026 - Tirzepatide vs Semaglutide: What the Trials Show
The two head-to-head trials, label differences and side effects, plus questions to ask a clinician. Updated October 20, 2026 - Compounded Tirzepatide vs Zepbound: What Actually Differs
FDA status, trial evidence, dosing and quality concerns, side by side, with the questions to ask a provider. Updated October 19, 2026 - Compounded GLP-1s Explained: What They Are and What to Ask
Prepared by a pharmacy for one patient, not FDA-approved. What that means and the questions to ask. Updated October 9, 2026
Every article in this guide is written by the The Health Brief editorial team and cites its sources, mostly FDA labels, peer-reviewed studies and professional guidelines. How we work.